Works matching IS 17555914 AND DT 2014 AND VI 32 AND IP 2
Results: 10
Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Patients with Multiple Sclerosis.
- Published in:
- Cardiovascular Therapeutics, 2014, v. 32, n. 2, p. 33, doi. 10.1111/1755-5922.12049
- By:
- Publication type:
- Article
Practical Considerations in the Use of Novel Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation.
- Published in:
- Cardiovascular Therapeutics, 2014, v. 32, n. 2, p. 74, doi. 10.1111/1755-5922.12048
- By:
- Publication type:
- Article
Xanthine Oxidase Inhibition for the Treatment of Cardiovascular Disease: A Systematic Review and Meta-Analysis.
- Published in:
- Cardiovascular Therapeutics, 2014, v. 32, n. 2, p. 57, doi. 10.1111/1755-5922.12059
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cardiovascular Therapeutics, 2014, v. 32, n. 2, p. i, doi. 10.1111/1755-5922.190
- Publication type:
- Article
Rosuvastatin Can Block Pro-Inflammatory Actions of Transgenic Human C-Reactive Protein Without Reducing its Circulating Levels.
- Published in:
- Cardiovascular Therapeutics, 2014, v. 32, n. 2, p. 59, doi. 10.1111/1755-5922.12061
- By:
- Publication type:
- Article
Percutaneous Mitral Repair with the Mitra Clip System in Patients with Mild-to-Moderate and Severe Heart Failure: A Single-Centre Experience.
- Published in:
- Cardiovascular Therapeutics, 2014, v. 32, n. 2, p. 66, doi. 10.1111/1755-5922.12058
- By:
- Publication type:
- Article
Cardiovascular Medication Use Following Percutaneous Coronary Intervention: The Australian Experience.
- Published in:
- Cardiovascular Therapeutics, 2014, v. 32, n. 2, p. 47, doi. 10.1111/1755-5922.12060
- By:
- Publication type:
- Article
The Effect of Simvastatin-Ezetimibe Combination Therapy on Adipose Tissue Hormones and Systemic Inflammation in Patients with Isolated Hypercholesterolemia.
- Published in:
- Cardiovascular Therapeutics, 2014, v. 32, n. 2, p. 40, doi. 10.1111/1755-5922.12057
- By:
- Publication type:
- Article
Advanced Interatrial Block is Associated with Recurrence of Atrial Fibrillation Post Pharmacological Cardioversion.
- Published in:
- Cardiovascular Therapeutics, 2014, v. 32, n. 2, p. 52, doi. 10.1111/1755-5922.12063
- By:
- Publication type:
- Article
An Update on the Clinical Development of Proprotein Convertase Subtilisin Kexin 9 Inhibitors, Novel Therapeutic Agents for Lowering Low-Density Lipoprotein Cholesterol.
- Published in:
- Cardiovascular Therapeutics, 2014, v. 32, n. 2, p. 82, doi. 10.1111/1755-5922.12056
- By:
- Publication type:
- Article